Monoclonal antibody to HER-2/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2/neu oncoprotein
- 31 January 2005
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 61 (1), 203-211
- https://doi.org/10.1016/j.ijrobp.2004.05.017
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 34 references indexed in Scilit:
- Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cellsOncogene, 2002
- Chemoradiotheraphy of Esophageal CancerActa Oncologica, 2002
- Prognostic significance of c -erb B-2 protein expression in carcinoma of the cervix treated with radiotherapyZeitschrift für Krebsforschung und Klinische Onkologie, 1999
- C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesionsEuropean Journal of Surgical Oncology, 1998
- Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cellsOncogene, 1998
- A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptorsOncogene, 1997
- Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosisEuropean Journal of Surgical Oncology, 1997
- Molecular and cellular features of esophageal cancer cellsZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Association of Elevated Expression of thec-erbB-2Protein with Spread of Breast CancerJapanese Journal of Cancer Research, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987